Figure 2.

Genomic heterogeneity of anaplastic lymphoma kinase (ALK) rearrangements and characteristics of patients with different EML4‐ALK variants. A, Frequency of EML4 and non‐EML4 partners of ALK fusions. B, Frequency of different EML4‐ALK fusion variants. C, Age difference between EML4‐ALK fusion variant V1 and variant V3 patients. D, Distribution of TP53 mutations between EML4‐ALK fusion variant V1 and variant V3 patients. WT, wild type